Dr. Lea K. Krekow works in the field of Oncology. She researched medicine at University of Texas Medical School. She has 1 awards "Meaningful Use Stage 1 Certification". Lea K. Krekow, MD is also a published doctor. She has 2 paper published. The most recent paper is: Adjuvant dose-dense doxorubicin plus cyclophosphamide followed by dose-dense nab-paclitaxel is safe in women with early-stage breast cancer: a pilot study. She is registered with Medicare and accepts Medicare payments.
Johns Hopkins University
University of Texas Health Science Center
University of Texas Medical School
North Hills Hospital| NPI NUMBER | 1982641361 | |
| NPPES Provider LastName | KREKOW | |
| NPPES Provider FirstName | LEA | |
| NPPES Provider ZIPCode | 760225934 | |
| NPPES Provider State | TX | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 1440.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 34.0 | |
| Percent Opioid Claims | 2.36 |
| National Provider Identifier [NPI] | 1982641361 |
| Last Name Of The Provider | KREKOW |
| First Name Of The Provider | LEA |
| View All |
|
Dr. Lee C. Drinkard, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Heidi A. Jordan, MD
This Doctor is OpenDoctor Recommended.
|